Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C as Adjunct in Periodontal Treatment for Uncontrolled T2DM
NCT03269799Phase 2
Key facts
- Status
- Unknown
- Start
- Aug 2017
- Primary completion
- Feb 2018
- Countries
- 1
- Sponsor
- Mahidol University
- Modality
- Small Molecules
- Drugs
- ascorbic acid
- Conditions
- periodontitis
01
Overview
Phase 2, randomised, double-blind trial in periodontitis comparing Vitamin C Group with Placebo Group (2 arms). Primary endpoint: Sulcus Bleeding Index at 8 weeks. Status: unknown.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Vitamin C Group
Non-surgical periodontal treatment + Vitamin C 500 mg/day
Placebo Group
Non-surgical periodontal treatment + Placebo
03
Who it enrols
Patients with uncontrolled type 2 diabetes mellitus and periodontitis, excluding those with complications like renal insufficiency, HIV, or taking specific interfering medications.
04
Endpoints
Primary
Sulcus Bleeding Index
Beyond the preview
Go deeper on NCT03269799.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03269799.